Wells Fargo & Company Vera Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 12,478 shares of VERA stock, worth $468,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,478
Previous 13,151
5.12%
Holding current value
$468,049
Previous $567,000
20.46%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VERA
# of Institutions
182Shares Held
54.7MCall Options Held
42.2KPut Options Held
121K-
Avoro Capital Advisors LLC New York, NY4.31MShares$162 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$136 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$125 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$111 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$105 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.01B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...